Programmed bacterial lysis in vivo alters host immune responses and microbial pathogenesis
To mimic T6SS-mediated killing, Lembke et al. engineer bacterial lysis strains and identify proinflammatory muropeptides that differentially trigger infant mouse intestinal immune signaling.